Revolutionary Therapeutics For Neuroendocrine Carcinoma Are Underway
Neuroendocrine carcinoma initiates in the hormone-producing cells of the neuroendocrine system…
Mesothelioma Awareness Day: How Clinical Trials Make A Difference
Each year, September 26th marks Mesothelioma Awareness Day, a time devoted…
Biotech is Game Changer in Cancer Treatment Advances
Whenever a new advance in cancer treatment occurs, it?s a momentous occasion.…
What is a Healthcare Innovation Really Worth?
Healthcare, even for the insured, can wreak extremely high financial costs for…
What is the Value of Hope in Cancer Care?
We have all heard about cancer treatments that cost $100,000 or more,…
Could Orphan Drugs Turn Health Economics on its Ear?
When is $100,000 a year more expensive than $500,000 a year? The…
Through the Murky Slog: Part II—A New Light for Cancer Therapies?
Last week, we discussed new drug approvals that reflected a paradigm shift…
Are We at the End of a Long, Murky Slog in Cancer Treatment?
For many years, a lot of people (including us) have called for…
Treating Cancer – Moving Beyond the Whack-a-Mole Approach
In his latest Wall Street Journal column (“Drugs That Are as Smart…